Point72 Asset Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-662,529
| Closed | -$4.54M | – | 1356 |
|
|
2023
Q3 | $4.54M | Sell |
662,529
-1,073,971
| -62% | -$7.36M | 0.01% | 724 |
|
|
2023
Q2 | $18M | Buy |
1,736,500
+391,900
| +29% | +$4.06M | 0.05% | 374 |
|
|
2023
Q1 | $10.9M | Sell |
1,344,600
-438,000
| -25% | -$3.54M | 0.03% | 476 |
|
|
2022
Q4 | $28.1M | Sell |
1,782,600
-70,651
| -4% | -$1.11M | 0.1% | 250 |
|
|
2022
Q3 | $29.2M | Buy |
1,853,251
+119,351
| +7% | +$1.88M | 0.12% | 223 |
|
|
2022
Q2 | $24.2M | Sell |
1,733,900
-543,200
| -24% | -$7.58M | 0.1% | 257 |
|
|
2022
Q1 | $39.3M | Buy |
2,277,100
+1,634,200
| +254% | +$28.2M | 0.16% | 165 |
|
|
2021
Q4 | $9.35M | Buy |
642,900
+251,600
| +64% | +$3.66M | 0.04% | 503 |
|
|
2021
Q3 | $7.04M | Sell |
391,300
-87,300
| -18% | -$1.57M | 0.03% | 544 |
|
|
2021
Q2 | $8.4M | Buy |
478,600
+150,800
| +46% | +$2.65M | 0.04% | 462 |
|
|
2021
Q1 | $8.26M | Buy |
+327,800
| New | +$8.26M | 0.04% | 445 |
|
|
2018
Q3 | – | Sell |
-269,922
| Closed | -$5.39M | – | 819 |
|
|
2018
Q2 | $5.39M | Sell |
269,922
-460,452
| -63% | -$9.19M | 0.02% | 471 |
|
|
2018
Q1 | $12.8M | Sell |
730,374
-61,626
| -8% | -$1.08M | 0.05% | 309 |
|
|
2017
Q4 | $19.5M | Sell |
792,000
-100,298
| -11% | -$2.47M | 0.08% | 250 |
|
|
2017
Q3 | $23M | Buy |
892,298
+29,896
| +3% | +$772K | 0.1% | 198 |
|
|
2017
Q2 | $23.4M | Buy |
862,402
+402,486
| +88% | +$10.9M | 0.13% | 184 |
|
|
2017
Q1 | $13.7M | Buy |
+459,916
| New | +$13.7M | 0.08% | 302 |
|